Fairmount Funds Management LLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
Fairmount Funds Management LLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$163,629,124
-2.9%
2,341,238
-0.2%
19.69%
-17.1%
Q2 2023$168,510,263
+35.8%
2,344,980
+16.6%
23.76%
+11.3%
Q1 2023$124,078,387
-20.0%
2,011,6470.0%21.34%
-13.3%
Q4 2022$155,158,333
+83.3%
2,011,647
+6.1%
24.61%
+65.5%
Q3 2022$84,628,000
+134.4%
1,896,647
+101.2%
14.88%
+80.1%
Q2 2022$36,100,000
-7.5%
942,5710.0%8.26%
-10.4%
Q1 2022$39,013,000
+450.5%
942,571
+402.4%
9.22%
+294.9%
Q4 2021$7,087,000
+14.6%
187,5980.0%2.34%
+3.9%
Q3 2021$6,183,000
-70.7%
187,598
-40.0%
2.25%
-74.1%
Q2 2021$21,088,000
+48.0%
312,598
+24.2%
8.67%
+44.4%
Q1 2021$14,245,000
-20.6%
251,598
+14.3%
6.00%
-6.4%
Q4 2020$17,931,000
+14.3%
220,0980.0%6.41%
-3.4%
Q3 2020$15,682,000
-11.8%
220,098
+1.9%
6.64%
-16.3%
Q2 2020$17,781,000
+59.4%
216,098
+14.0%
7.93%
+17.2%
Q1 2020$11,154,000189,5986.76%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,132,645$37,332,00032.86%
MORGAN JESS S & CO INC 113,430$3,739,0002.47%
Fairmount Funds Management LLC 187,598$6,183,0002.25%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,423,653$46,924,0001.43%
WMS Partners, LLC 250,000$8,240,0001.21%
Beck Bode, LLC 102,127$3,366,0000.94%
RTW INVESTMENTS, LP 1,616,497$53,280,0000.80%
MPM BioImpact LLC 110,155$3,631,0000.56%
Endurant Capital Management LP 52,048$1,716,0000.39%
Bellevue Group AG 752,945$24,817,0000.25%
View complete list of AXSOME THERAPEUTICS INC shareholders